Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Kojima

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Mabs|December 20, 2014
Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activityZenjiro Sampei, Tomoyuki Igawa, Tetsuhiro Soeda, et al.
Cancer Science|January 6, 2011
Deficiency of the Erc/mesothelin gene ameliorates renal carcinogenesis in Tsc2 knockout miceDanqing Zhang, Toshiyuki Kobayashi, Tetsuo Kojima, et al.
Plos One|March 8, 2013
Identification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activityZenjiro Sampei, Tomoyuki Igawa, Tetsuhiro Soeda, et al.
Nature Biotechnology|October 19, 2010
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralizationTomoyuki Igawa, Shinya Ishii, Tatsuhiko Tachibana, et al.
Bioorganic & Medicinal Chemistry|July 9, 2024
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA displayMirai Kage, Ryuji Hayashi, Atsushi Matsuo, et al.
Nature Medicine|October 2, 2012
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A modelTakehisa Kitazawa, Tomoyuki Igawa, Zenjiro Sampei, et al.
Journal of the American Chemical Society|October 24, 2023
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough TargetsAtsushi Ohta, Mikimasa Tanada, Shojiro Shinohara, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Mabs|December 20, 2014
Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activityZenjiro Sampei, Tomoyuki Igawa, Tetsuhiro Soeda, et al.
Cancer Science|January 6, 2011
Deficiency of the Erc/mesothelin gene ameliorates renal carcinogenesis in Tsc2 knockout miceDanqing Zhang, Toshiyuki Kobayashi, Tetsuo Kojima, et al.
Plos One|March 8, 2013
Identification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activityZenjiro Sampei, Tomoyuki Igawa, Tetsuhiro Soeda, et al.
Nature Biotechnology|October 19, 2010
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralizationTomoyuki Igawa, Shinya Ishii, Tatsuhiko Tachibana, et al.
Bioorganic & Medicinal Chemistry|July 9, 2024
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA displayMirai Kage, Ryuji Hayashi, Atsushi Matsuo, et al.
Nature Medicine|October 2, 2012
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A modelTakehisa Kitazawa, Tomoyuki Igawa, Zenjiro Sampei, et al.
Journal of the American Chemical Society|October 24, 2023
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough TargetsAtsushi Ohta, Mikimasa Tanada, Shojiro Shinohara, et al.
Pageof 2